Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne R Stochaj

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
CSH Protocols|March 2, 2011
Mass spectrometry-compatible silver stainingWayne R Stochaj, Tom Berkelman, Nancy Laird
CSH Protocols|April 10, 2012
Preparative 2D Gel Electrophoresis with Immobilized pH Gradients: IEF of Proteins in an IEF-Dedicated Electrophoresis UnitWayne R Stochaj, Tom Berkelman, Nancy Laird
Scientific Reports|April 27, 2021
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulationElla Fung, Liya Kang, Diana Sapashnik, et al.
Mabs|January 18, 2021
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
CSH Protocols|March 2, 2011
Mass spectrometry-compatible silver stainingWayne R Stochaj, Tom Berkelman, Nancy Laird
CSH Protocols|April 10, 2012
Preparative 2D Gel Electrophoresis with Immobilized pH Gradients: IEF of Proteins in an IEF-Dedicated Electrophoresis UnitWayne R Stochaj, Tom Berkelman, Nancy Laird
Scientific Reports|April 27, 2021
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulationElla Fung, Liya Kang, Diana Sapashnik, et al.
Mabs|January 18, 2021
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.
Pageof 2